Modern Edge Family Practice

Blog

All Blogs
How to Prevent Muscle Loss While Taking Semaglutide or Tirzepatide

How to Prevent Muscle Loss While Taking Semaglutide or Tirzepatide

August 12, 2026
5 Minute Read

The Goal Is Better Body Composition, Not Just a Lower Scale Number

Semaglutide and tirzepatide can reduce appetite and support substantial weight loss when prescribed appropriately. Any meaningful weight loss can include both fat mass and lean mass. The aim is not to prevent every ounce of lean-mass change. It is to preserve as much functional muscle as reasonably possible while reducing excess fat.

At Modern Edge Family Practice in Albuquerque, we pair medical weight management with nutrition, strength training guidance, follow-up, and InBody measurements. Medication is one tool inside a broader plan.

Prioritize Protein Consistently

When appetite decreases, protein can unintentionally fall too low. Build meals around a tolerable protein source first: eggs, Greek yogurt, cottage cheese, fish, poultry, lean meat, tofu, beans, or a protein shake when needed. Spreading protein across the day is usually easier than trying to catch up with one very large meal.

The appropriate target depends on body size, goal weight, kidney health, age, activity, and total intake. A clinician or dietitian can help individualize it. Patients with kidney disease or other relevant conditions should not adopt a high-protein target without medical guidance.

Strength Training Is the Strongest Signal to Keep Muscle

  • Perform resistance exercise at least two or three days per week if medically able.
  • Train major movement patterns: squat or leg press, hinge, push, pull, carry, and core stabilization.
  • Use a level that becomes challenging near the end of the set while maintaining safe technique.
  • Progress gradually by adding repetitions, resistance, range of motion, or control.
  • Include balance and functional training when age, injury, or deconditioning makes it appropriate.

Avoid Losing Weight Faster Than Your Body Can Support

Severe nausea, persistent vomiting, inability to meet basic nutrition needs, or an excessively rapid decline in weight may indicate that the treatment plan needs reassessment. Increasing a dose simply because the next dose exists is not always the right decision. The best dose is the one that provides clinically useful appetite and weight control with tolerable adverse effects and sustainable nutrition.

Never split, combine, or escalate prescription doses without the prescriber's direction. FDA-approved semaglutide and tirzepatide products have specific dosing schedules and warnings.

Support Recovery

  • Sleep seven to nine hours when possible. Untreated sleep apnea and chronic sleep restriction undermine recovery.
  • Maintain hydration, especially when nausea, diarrhea, heat, or exercise increases fluid loss.
  • Include adequate calories, fiber, and micronutrient-rich foods rather than relying only on supplements.
  • Address pain or mobility limitations so an appropriate exercise plan remains possible.
  • Limit excessive alcohol, which can interfere with nutrition, sleep, and training.

Track More Than Weight

Waist measurement, gym performance, daily function, protein intake, symptoms, and body composition provide context that the scale cannot. Bioelectrical impedance devices such as InBody are most useful when conditions are kept similar. Hydration, meal timing, recent exercise, clothing, and time of day can all shift results.

One scan should not trigger a major treatment change. Trends measured under consistent conditions are more informative.

A Medical Weight-Loss Plan Built Around Health

Modern Edge Family Practice offers personalized semaglutide and tirzepatide programs, laboratory evaluation, ongoing check-ins, and InBody monitoring in Albuquerque. Our goal is sustainable fat loss while protecting strength, energy, and long-term health.

Call (505) 370-9195 or learn more about our medical weight loss program to request a consultation.

Sources and Further Reading

  • U.S. Food and Drug Administration, current semaglutide and tirzepatide prescribing information.
  • American College of Sports Medicine, resistance training guidance.
  • American Diabetes Association, obesity and weight-management guidance.

Medical disclaimer: This article is for general education and marketing purposes and does not replace individualized medical evaluation, diagnosis, or treatment. Services and candidacy vary. Call 911 for an emergency.

Read More Blogs!

Stay updated with the latest blog posts and engage with our community.